| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | | Total Revenue |
-
|
-
| | Cost of Revenue | 8,854 |
-
| | | Gross Profit | (8,854) |
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 2,865 | 4,057 | | Non Recurring |
-
|
-
| | Others | 32 | 22 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (11,752) | (4,080) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (446) | (10,154) | | Earnings Before Interest And Taxes | (12,198) | (4,222) | | Interest Expense |
-
|
-
| | Income Before Tax | (12,198) | (4,222) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (12,198) | (14,233) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (12,198) | (14,233) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($12,198) | ($14,233) |
|
0.20% Nasdaq 
Income Statement
